"It would be better for RGS to publish the results of their trial for peer review"...once more....I think if you read it again, you will see they said that is exactly what they intend to do.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025